Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 403
Selected: 0
NCT IDTitle
NCT06090630MR Correlated Spectroscopic Imaging for Diagnosing Breast Cancer
NCT00079222Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
NCT01826877Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer
NCT05558904An Investigational Scan (Me-4FDG PET/CT) for the Detection of Sodium-Glucose Transport for Early Diagnosis of Lung Cancer
NCT01180907The Biodistribution of 1-[2 Deoxy-2, -18 Fluroarabinfuranosyl]Cytosine [18FAC] in Healthy Subjects and Patients With Cancer, Autoimmune/Inflammatory Diseases
NCT06047509Focal Laser Ablation of Prostate Cancer: A Feasibility Study Using MRI/US Image Fusion for Guidance
NCT00949819Active Surveillance for Cancer of the Prostate (ASCaP)
NCT00509431Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
NCT00081068Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia
NCT01540955Cognitive Rehabilitation Group Intervention for Breast Cancer Survivors
NCT00004979Topotecan and Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Advanced Solid Tumors
NCT00910650Study of Gene Modified Immune Cells in Patients With Advanced Melanoma
NCT00646633Improving Fatigue: A Pilot Study of Acupuncture and Patient Education for Breast Cancer Survivors
NCT00005024Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease
NCT06059690Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
NCT00003225Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer
NCT02880020Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery
NCT03541850Stereotactic Body Radiation Therapy in Treating Patients With Localized Prostate Cancer That Have Undergone Surgery
NCT05720988Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia
NCT05496959177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study
NCT00005996SU5416 Combined With Gemcitabine and Cisplatin in Treating Patients With Advanced Solid Tumors
NCT00081042ABI-007 in Treating Patients With Inoperable Locally Recurrent or Metastatic Melanoma
NCT03202472Radiofrequency Identification Technology in Locating Non-palpable Breast Lesions in Patients Undergoing Surgery
NCT05256641Acalabrutinib Maintenance for the Treatment of Patients With Large B-cell Lymphoma
NCT00460200Depression and Interleukin-6 Production in Patients With Ovarian Epithelial Cancer
NCT00719030A Study Of the Effectiveness Of Pomegranate Pills in Men With Prostate Cancer Before Prostatectomy
NCT03732950Pembrolizumab in Treating Participants With Recurrent Ovarian Cancer
NCT05950113CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT00033514Trastuzumab and Erlotinib as First-Line Therapy in Treating Women With Metastatic Breast Cancer Associated With HER2/Neu Overexpression
NCT03546361CCL21-Gene Modified Dendritic Cell Vaccine and Pembrolizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer
NCT00055926CP-724,714 in Treating Patients With Metastatic Breast Cancer
NCT00998010Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
NCT01149850Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
NCT04119024Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
NCT06568016A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
NCT00955591Comparing Two Types of Swabs in Collecting Cell Samples for Anal Pap Tests and Human Papillomavirus Tests in Men Who Have Sex With Men
NCT03506802TCR Genetically Engineered PBMC and PBSC After Melphalan Conditioning Regimen in Treating Participants With Relapsed and Refractory Multiple Myeloma
NCT0485750299mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
NCT02826395C11 Sodium Acetate PET/CT Imaging of PCa
NCT04420975Nivolumab and BO-112 Before Surgery for the Treatment of Resectable Soft Tissue Sarcoma
NCT01345136Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
NCT00005082Magnetic Resonance Imaging in Determining Extent of Cancer in Patients With Newly Diagnosed Glioma
NCT00020761Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach
NCT00096057Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer
NCT07517211A Prospective Study of Physical Function in Adults Who Receive Systemic Therapy for Stage I-III Gastroesophageal Cancer, FAST-GO Study
NCT05978128Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
NCT00112749Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer
NCT02092948Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic Cancer
NCT00706615Vaccine Therapy in Treating Women With Previously Treated Metastatic Breast Cancer
NCT01783756Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis